INTRODUCTION
============

The incidence of deep venous thrombosis (DVT) is highly dependent on the population studied and on the definition of DVT used. Moreover, in Korea, the prevalence of DVT is increasing ([Table 1](#T1){ref-type="table"}). The true incidence of this disease as quoted by previous epidemiological studies are generally underestimated because study populations have been restricted to those who present at hospitals and are then diagnosed as having DVT. Furthermore, one autopsy study concluded that up to 50% of venous thromboembolisms is overlooked ante mortem.[@B1]

Two main complications of DVT are pulmonary embolism and post-thrombotic syndrome (PTS), and the incidence of PTS is higher in patients that only receive anticoagulation for the management of DVT.[@B2] Most physicians consider that the delivery of a thrombolytic agent into a thrombus is more effective than systemic anticoagulation because this procedure reduces the complication rate of systemic anticoagulation.[@B1],[@B2] Contemporary venous thrombectomy has been reported to improve early and long term results in extensive iliofemoral DVT as compared with simple catheter-directed thrombolysis.[@B3],[@B4] Furthermore, several percutaneous thrombectomy devices have been recently released,[@B4],[@B5] and replaced conventional thrombectomy. The aim of this study is to evaluate the clinical efficacy of catheter-directed thrombolysis with conventional aspiration thrombectomy for the treatment of lower extremity deep vein thrombosis, and to document clinical outcomes.

MATERIALS AND METHODS
=====================

The hospital records of 74 patients diagnosed with symptomatic DVT from October 2004 to December 2007 were analyzed retrospectively. The male/female ratio was 34/40, and mean patient age was 60 ± 15 years. Sixty-eight patients (92%) complained of leg swelling, and 40 patients (54%) of leg pain. Mean symptom duration of the patients was 8.4 ± 12.1 days, with a median of 4 days and a range of 1 to 60 days. Patient characteristics are summarized in [Table 2](#T2){ref-type="table"}. Risk factors for hypercoagulability are listed in [Table 3](#T3){ref-type="table"}. Diagnoses were established by color duplex ultrasound imaging or MDCT venography or venography, which was performed in an angiography suite. We performed MDCT pulmonary angiography to detect for a pulmonary embolism in all patients.

All patients underwent aspiration thrombectomy first and then a catheter-directed thrombolysis. A prophylactic retrievable IVC filter (OptEase, Cordis, Miami, FL, USA) was inserted in 15 patients with a free floating thrombus into the IVC or common iliac vein, in 10 patients diagnosed with pulmonary embolism at admission, or in 35 patients with both. For venous access, a patient was placed in a prone position and the ipsilateral popliteal vein was accessed using a micropuncture needle kit (Micropuncture introducer set, Cook, Bloomington, IN, USA) under ultrasound guidance (Logiq P5 premium, GE, Seongnam, Korea). After an initial ascending venogram had been obtained using a 9 F introducer sheath (Radifocus introducer II, Terumo, Leuven, Belgium), direct aspirations of the embolus were performed several times using an 8F guiding catheter (Vistabrite tip, Cordis, Miami, FL, USA) while maintaining negative pressure with a 50 mL syringe. Stent placement was indicated if the left common iliac vein was compressed after embolus aspiration. Stents were placed over a guide wire into the left common iliac vein and were typically between 10 to 14 mm in diameter and 60 to 90 mm long (Wallstent, Boston Scientific, Galway, Ireland). Stent dilatation was achieved using a balloon catheter (BlueMax 20, Boston Scientific, Galway, Ireland).

After the thrombectomy with or without stent placement, thrombolysis was performed by placing a 20 cm multi-side hole thrombolysis catheter (Multisideport catheter infusion set, Cook, Bloomington, IN, USA) into the thrombosed vein. The procedure started by infusing urokinase (GCC-Urokinase, Green Cross, Yongin, Korea) at a rate of 80,000 to 120,000 IU/hour; the rate used depended on the patient\'s condition, amount of thrombus, and the patient\'s weight. Venography was carried out 12 hour later to evaluate the progress of thrombolysis and to correct the catheter position. Infusion was continued for a further 24 hours if the thrombus had not completely resolved. Anticoagulation was carried out after thrombolysis by continuously infusing heparin to a partial thromboplastin time of 70-90 seconds, which was subsequently checked at 6-hour intervals. The subsequent treatment protocol included oral anticoagulation with warfarin to a target international normalized ratio of 2.0-2.5 for 3 months. The retrieval IVC filter was removed at 2 weeks postoperatively from 46 (76%) patients with optimal patency by MDCT venography. It was left behind for permanent use in 14 (24%) patients with suboptimal patency by MDCT venography. Thrombus removal was defined as complete if the MDCT venogram at discharge showed no evidence of a residual clot ([Fig. 1A](#F1){ref-type="fig"}), and partial thrombus removal was defined if any residual clot was visualized ([Fig. 1B](#F1){ref-type="fig"}). Treatment failure was defined as near total obstruction of the venous lumen by thrombus ([Fig. 1C](#F1){ref-type="fig"}). Follow-up examinations were performed at 6 months postoperatively by MDCT venography. In addition, a telephone interview was conducted with each patient during September 2008 by a trained nurse to determine the clinical outcome and clinical symptoms; outcomes were defined as asymptomatic, moderately improved, mildly improved, unchanged, mildly worsened, moderately worsened, and considerably worsened.

RESULTS
=======

Thrombosis was located on the left side in 58 (78%) patients and on the right side in 16 (22%) patients. The IVC was affected in 6 (8%) patients. Thrombosis was involved up to the supra inguinal segments in 57 (77%) patients, and up to the infra inguinal segments in 17 (23%) patients. Pulmonary embolism was diagnosed in 45 (61%) patients. Clinical improvement, as defined by a decrease in pain and/or swelling of the affected extremity within 48 hours of intervention, was displayed by 67 (91%) patients. Primary stent placement for segmental stenosis was necessary in 37 (50%) patients. The mean urokinase infusion time was 31 (8-48) hours, and the mean amount of urokinase delivered was 2,630,000 ± 1,083,000 units. Complete thrombus removal was achieved in 15 (20%) patients, and partial thrombus removal in 52 (70%) by MDCT venography at discharge. Treatment failure occurred in 7 (9%) patients ([Table 4](#T4){ref-type="table"}). Four (5%) bleeding complications related to thrombolysis occurred. However, only one patient had a major bleeding complication and retroperitoneal hematoma, and required a blood transfusion. DVT recurrence was diagnosed with a Doppler study and MDCT venography in 6 (8%) patients. These patients were readmitted for further treatment. Postthrombotic syndrome, defined as affected limb edema, pigmentation, pain, and/or venous insufficiency by a Doppler study, was noted in 28 (38%) patients at 3.0 ± 4.2 months postoperatively. MDCT venography showed complete thrombus removal in 50 (72%) patients, partial removal in 15 (22%), and treatment failure in 4 (6%) during the 5.7 ± 5.6 month follow-up ([Table 4](#T4){ref-type="table"}). The mean clinical follow-up interval was 22.8 ± 10.7 months, and 61 patients among the 74 patients were accessed via a telephone interview (81%). Twenty-eight of the 61 (46%) telephone patients were asymptomatic, twenty-eight (46%) had moderate improvement, and four (6%) were mildly improved.

DISCUSSION
==========

Epidemiologic studies have shown that DVT is highly prevalent in western populations. The incidence of venographically confirmed DVT in Sweden has been reported to be as high as 160 cases of new or recurring DVT per 100,000 of the population per year,[@B6] and 116,000 to more than 250,000 new cases of clinically recognized DVT per year are recorded in the United States.[@B7] The Korean Health Insurance Review & Assessment Service reported that in 2007, 51 per 100,000 of the population were treated for new or recurring DVT, and that the incidence of this disease is increasing ([Table 1](#T1){ref-type="table"}). The causes of this increase are multifactorial, but the main reason is likely to be a Westernization of diet resulting from economical development in the past 20 years. The number of May-Thurner syndrome patients was 34 (46%), which was higher than that reported previously. [@B5] There is a reason why the left limb was more frequently involved (80% vs. 20%) in our population. Patients with anatomical compression of the left common iliac vein by the left common iliac artery are prone to develop venous flow stasis in the left leg. Husmann, et al.[@B8] reported that combined thrombolysis and stenting of a common iliac vein obstruction is effective. Our results showed a good 6 months MDCT venography follow-up in patients with stent placement. The incidence of hypercoagulable disorder was 29%, which is lower than the 78% previously reported.[@B9] Differences between the above-mentioned predisposing risk factors may be due to racial differences.

Numerous studies have reported positive outcomes for catheter-directed thrombolysis in acute DVT.[@B1]-[@B3],[@B5] Mewissen, et al.[@B10] documented a complete resolution rate of 31%, a partial rate of 52%, and a failure rate of 17%, whereas Verhaeghe, et al.[@B11] reported a complete resolution rate of 79% and a failure rate of 21%. In the present study, the complete resolution rate was 20%, the partial resolution rate was 70%, and the failure rate was 10%. Our immediate complete resolution rate was lower than those of these other reports. The duration of symptoms at the onset of lytic therapy was predictive of lytic outcome.[@B10] For acute cases (less than 10 days), the prevalence of complete lysis was 34% compared with 19% in cases with a history of chronic DVT (\> 10 days).[@B10] The median was 4 days duration of symptoms in our cases although the range was up to 60 days. It may result from different patients\' compositions such as more May-Thurner syndrome patients, or higher rate of suprainguinal DVT involvement than other reports.

Catheter directed thrombolysis with adjunctive mechanical thrombus removal is becoming the standard for the catheter based management of DVT,[@B1],[@B2] and contemporary venous thrombectomy has substantially improved early and long term results.[@B1]-[@B3],[@B5] Numerous devices have been recently released for pharmacomechanical thrombolysis.[@B3],[@B5] We performed a mechanical thrombectomy by manual aspiration, i.e., we did not use the thrombectomy devices. It is difficult to use newly developed catheters, such as the Trellis catheter, the AngioJet system, or an ultrasound incorporating system in our public health system because public health insurance does not cover the cost of the catheters. However, Lin, et al.[@B5] showed no statistical difference between thrombus removal rates for the pharmacomechanical thrombectomy using the AngioJet system and catheter direct thrombolysis. The complete thrombus free rate was 67% in the present study and 75% for Angiojet catheter-directed thrombolysis in the report by Lin, et al.[@B5] The conventional manual aspiration can be an alternative for thrombectomy in the absence of special catheter systems.

Acute pulmonary embolismis a major morbidity of acute DVT.[@B1],[@B2] In our study cohort, we used a temporary IVC filter in 60 (81%) of the patients to prevent thrombus embolization during the procedures. Currently, prophylactic IVC filter placement is performed without departmental guidelines. IVC filter insertion is recommended in patients with a free floating IVC thrombus that is longer than 5 cm.[@B1] The incidence of preoperative pulmonary embolism at admission in our study was 61%, which was higher than the 10-26% previously reported.[@B11],[@B12] This may have been due to a higher rate of suprainguinal DVT involvement in our patients (77%), or routine preoperative MDCT pulmonary angiography check up. Post-thrombotic syndrome, which is the most important late complication, has been reported to occur in 29% to 79% of acute DVT cases.[@B14] Valvular insufficiency and residual obstruction are primary contributors to venous hypertension, which may result in limb edema, hyperpigmentation, or ulceration.[@B15] Experimental reports on acute DVT in canine models have demonstrated that thrombolysis preserves endothelial function and valve competence.[@B16] Early post-thrombotic syndrome in our cohort at a 3 month follow-up (39%) could be lower on later follow up periods, considering that the 20% complete thrombus removal rate at discharge improved to 67% on a 6 months follow-up. Our mid-term follow up via telephone interview (81%) showed asymptomatic in 46% of patients and moderate improvement in 46%.

The reported complications of catheter-directed thrombolysis are bleeding, pulmonary embolism, and death.[@B1],[@B2] In the present study, there was no death. 5% of patients developed a bleeding complication, but only one case had a retroperitoneal hematoma and required a transfusion.

We conclude that catheter-directed thrombolysis by conventional aspiration thrombectomy is an effective treatment for lower extremity deep vein thrombosis, and the clinical results achieved were satisfactory.
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![MDCT angiograms showing complete thrombus removal (A), partial thrombus removal (B), and treatment failure (C). Each A-1, B-1, C-1 are in an axial view before thrombolysis at the level above the iliac vein (arrow), and A-2, B-2, C-2 are in an axial view after thrombolysis at the level of the superficial femoral vein (arrow). MDCT, multi detector computerized tomographic.](ymj-51-197-g001){#F1}
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